本文へスキップ

医薬品リファレンス

Luspatercept

Luspatercept is a medicine in the class miscellaneous. It is used for anemia.

最終更新日 出典: US FDA label

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

要点

薬効分類
Miscellaneous
ATCコード
B03XA06
一般的な剤形
注射剤
一般的な規格
25 mg
商品名
3
国・市場
3

剤形、規格、商品名は国によって異なります。お手元の製品をご確認ください。

何に使われるか

作用のしくみ

Recombinant fusion protein that binds several endogenous TGF-β superfamily ligands, diminishing Smad2/3 signaling and promoting erythroid maturation, thereby increasing erythropoiesis.

成人の通常用量(添付文書の要約)

Beta thalassemia anemia requiring regular RBC transfusions: start 1 mg/kg subcutaneously once every 3 weeks; increase to 1.25 mg/kg if no reduction in RBC transfusion burden; maximum 1.25 mg/kg

添付文書の最初の用法・用量の行のみの要約です。用法・用量の全項目はアプリでご覧いただけます。

妊娠と授乳

妊娠
Unsafe May cause fetal harm: in rats and rabbits it caused fetal death, poor growth and malformations. No human data. Do not use in pregnancy; women who could become pregnant need a pregnancy test before starting and effective contraception during treatment and for 3 months after.
授乳
Unknown No human milk data; it passes into rat milk. LactMed: as a large protein, milk levels are likely very low and poorly absorbed, but no data yet. US label: breastfeeding not recommended during treatment and for 3 months after the last dose.

報告されている副作用

  • Fatigue
  • Headache
  • Musculoskeletal pain
  • Arthralgia
  • Dizziness/vertigo
  • Nausea

注意が必要な方

  • Thromboembolic events reported in beta thalassemia; consider thromboprophylaxis in at-risk patients and monitor.
  • Hypertension: monitor blood pressure before each administration and treat with antihypertensives.
  • Extramedullary hematopoietic masses in beta thalassemia; monitor and discontinue for serious complications.

妊娠中または授乳中であること、腎臓や肝臓の病気、アレルギー、ほかに使用しているすべての薬やサプリメントについて、薬剤師または医師にお伝えください。

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、Luspaterceptの完全なモノグラフ(用量、妊娠・授乳、副作用、警告、すべての相互作用)を表示できます。

  • Dosing by age, kidney and liver function, and further dose lines
  • Renal and hepatic dose adjustments
  • Dosing in older adults
  • How to give it
  • Pharmacokinetics
  • Patient counselling points
  • IV preparation and dilution

WebでPro+を7日間無料でお試し。カード登録不要。

同じ分類のほかの薬剤

よくある質問

What is Luspatercept used for?

Luspatercept is a medicine in the class miscellaneous. It is used for Anemia, Myelodysplastic syndromes, Thalassemia.

What side effects have been reported with Luspatercept?

Fatigue, Headache, Musculoskeletal pain, Arthralgia, Dizziness/vertigo, Nausea.

Can Luspatercept be taken in pregnancy or while breastfeeding?

Pregnancy: Unsafe. May cause fetal harm: in rats and rabbits it caused fetal death, poor growth and malformations. No human data. Do not use in pregnancy; women who could become pregnant need a pregnancy test before starting and effective contraception during treatment and for 3 months after. Breastfeeding: Unknown. No human milk data; it passes into rat milk. LactMed: as a large protein, milk levels are likely very low and poorly absorbed, but no data yet. US label: breastfeeding not recommended during treatment and for 3 months after the last dose.

What does Luspatercept interact with?

MediHelp does not list a checked interaction for Luspatercept yet. Always tell your pharmacist about every medicine you take.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

A–Zで探す · 医薬品リファレンス

アプリを入手 ログイン